Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Bio-Rad Laboratories, Inc.
BIO
$297.17
Name : Bio-Rad Laboratories, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $7,952,744,448.00
EPSttm : 6.12
finviz dynamic chart for BIO
Bio-Rad Laboratories, Inc.
$297.17
2.01%
$5.86
BIO — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.48

Margin Of Safety %

-10

Put/Call OI Ratio

0.11

EPS Next Q Diff

0.42

EPS Last/This Y

-18.87

EPS This/Next Y

0.72

Price

297.38

Target Price

301.25

Analyst Recom

2.71

Performance Q

11.03

Upside

-55.1%

Beta

1.09

Ticker: BIO




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-05-11BIO243.910.400.251881
2026-05-12BIO241.960.401.501885
2026-05-13BIO243.440.390.001882
2026-05-14BIO246.260.39999.991882
2026-05-15BIO247.610.390.021882
2026-05-18BIO282.040.210.29587
2026-05-19BIO281.270.220.13615
2026-05-20BIO287.590.221.10622
2026-05-21BIO286.780.233.00637
2026-05-22BIO287.950.256.00648
2026-05-26BIO296.970.250.50649
2026-05-27BIO305.210.250.08650
2026-05-28BIO3180.250.24658
2026-05-29BIO312.330.260.00666
2026-06-02BIO305.670.260.00678
2026-06-03BIO304.60.110.291443
2026-06-04BIO307.510.110.431452
2026-06-05BIO294.320.110.431452
2026-06-08BIO291.350.112.001453
2026-06-09BIO297.060.112.001453
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-05-11BIO243.88-29.764.09.17
2026-05-12BIO241.79-29.772.99.17
2026-05-13BIO243.56-29.777.99.17
2026-05-14BIO246.10-29.779.59.17
2026-05-15BIO247.82-29.770.69.17
2026-05-18BIO281.82-27.6117.09.11
2026-05-19BIO281.23-27.667.89.11
2026-05-20BIO287.79-27.683.99.11
2026-05-21BIO286.75-27.675.59.11
2026-05-22BIO287.74-27.677.99.11
2026-05-26BIO297.16-33.188.59.00
2026-05-27BIO305.41-33.189.19.00
2026-05-28BIO318.12-33.187.19.00
2026-05-29BIO311.99-33.165.59.00
2026-06-01BIO305.45-33.165.99.00
2026-06-02BIO306.03-33.174.59.00
2026-06-03BIO304.72-33.170.99.00
2026-06-04BIO307.47-33.175.79.00
2026-06-05BIO294.36-33.149.89.00
2026-06-08BIO291.45-33.158.39.00
2026-06-09BIO297.38-33.168.09.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-05-11BIO0.00-2.305.95
2026-05-12BIO0.00-2.306.09
2026-05-13BIO-0.01-2.306.09
2026-05-14BIO-0.01-2.306.09
2026-05-15BIO-0.01-2.306.09
2026-05-18BIO-0.01-3.426.09
2026-05-19BIO-0.01-3.426.09
2026-05-20BIO-0.01-3.426.09
2026-05-21BIO-0.01-3.426.09
2026-05-22BIO-0.01-3.426.09
2026-05-26BIO-0.016.546.09
2026-05-27BIO-0.016.546.09
2026-05-28BIO-0.016.547.48
2026-05-29BIO-0.016.547.48
2026-06-02BIO-0.015.197.48
2026-06-03BIO-0.015.197.48
2026-06-04BIO-0.015.197.48
2026-06-05BIO-0.015.197.48
2026-06-08BIO-0.015.107.48
2026-06-09BIO-0.015.107.48
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

1.89

Avg. EPS Est. Current Quarter

1.75

Avg. EPS Est. Next Quarter

2.31

Insider Transactions

-0.01

Institutional Transactions

5.1

Beta

1.09

Average Sales Estimate Current Quarter

623

Average Sales Estimate Next Quarter

651

Fair Value

267.44

Quality Score

73

Growth Score

41

Sentiment Score

20

Actual DrawDown %

64.3

Max Drawdown 5-Year %

-73.8

Target Price

301.25

P/E

48.95

Forward P/E

29.84

PEG

7.54

P/S

3.1

P/B

1.16

P/Free Cash Flow

22.48

EPS

6.07

Average EPS Est. Cur. Y​

9

EPS Next Y. (Est.)

9.72

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.52

Relative Volume

1.15

Return on Equity vs Sector %

-25

Return on Equity vs Industry %

-9.3

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-1.26

EBIT Estimation

68
BIO Healthcare
$297.39
📉
Swing / Pullback
Buy the dip on strong trends
38 /100
WEAK
Trend
10/20
Pullback
8/25
Volume
4/15
Valuation
10/20
TP/AR
0/10
Options
6/10
RSI
55.6
Range 1M
71.3%
Sup Dist
2.9%
🚀
Momentum Growth
Ride accelerating trends
N/A
31 /100
WEAK
Momentum
6/25
Growth
5/30
Estimates
3/20
Inst/Vol
10/15
Options
7/10
EPS Yr
-8.9%
EPS NY
10.2%
52W%
60.8%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -16.8% upside
Quality
8/30
Valuation
4/30
Growth
3/25
Stability
8/10
LT Trend
4/5
Upside
-16.8%
Quality
73
MoS
-10%
Bio-Rad Laboratories, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 7450
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
BIO

Latest News

Caricamento notizie per BIO
stock quote shares BIO – Bio-Rad Laboratories, Inc. Stock Price stock today
news today BIO – Bio-Rad Laboratories, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch BIO – Bio-Rad Laboratories, Inc. yahoo finance google finance
stock history BIO – Bio-Rad Laboratories, Inc. invest stock market
stock prices BIO premarket after hours
ticker BIO fair value insiders trading